Resize Text Search
  • Schedule an Appointment
  • Find a Doctor
  • Locations
Patient Information
Doctor Appointment
 
 
 

Kevin H. Silver, MD, FACC, FSCAI, FASNC
(330) 376-7000

Summa Physicians Inc. - Interventional Cardiology

Specialties:

  • Interventional Cardiology
  • Cardiovascular Disease

Gender:

Male

Locations

Education

  • 1986: Columbia University College of Physicians and Surgeons, New York City, (M.D.)
  • 1982: Brown University, Providence, R.I.  (Sc.B. Chemistry with Honors)

Post-Graduate Training

University of Massachusetts Medical Center, Worcester, MA.

  • 1993-94: Interventional Fellow in Cardiovascular Medicine
  • 1992-93: Chief Fellow in Cardiovascular Medicine 
  • 1990-93: Fellow in Cardiovascular Medicine
  • 1989-90: Chief Resident in Internal Medicine
  • 1987-89: Resident in Internal Medicine
  • 1986-87: Intern in Internal Medicine

Bio

Clinical Skills and Privileges

  • Percutaneous Coronary Intervention
    • High Risk and Acute Interventions
    • Chronic Total Occlusions
    • Stem Cell Therapy
  • Thallium and SestaMIBI Authorized User – Ohio
  • Clinical and Consultative Cardiology

Clinical Appointments

  • 2013 - Associate Director, Cardiology Fellowship Program, Akron City Hospital Department of Cardiovascular Medicine, Akron, OH.
  • 2009- Attending Physician, Summa Western Reserve Hospital, Cuyahoga Falls, OH
  • 2008- Interventional Cardiologist, SUMMA Physicians Incorporated  (SPI), Akron, OH.  (dba NEOCS)
  • 2007- Partner, Northeast Ohio Cardiovascular Specialists (dba NEOCS), Akron, OH
    (formerly, Akron Cardiology Consultants)
    Associate 1999-2001, Partner & Vice-President 2001-
  • 2007- Director, Cardiovascular Medical Education, Akron City Hospital, Akron, OH
  • 2004- Director, Coronary Care Unit, Akron City Hospital, Akron, OH.
  • 2004- Director, Post-PCI Unit, Akron City Hospital, Akron, OH.
  • 2007-2013 Director, Clinical Research, NEOCS, Akron, OH
  • 2009-2011 Director, Mobile Nuclear Services and Radiation Safety Officer, NEOCS
  • 2003-2009 Medical Director, Angiographic Laboratory, LLC.  Akron, OH.
  • 2003-2009 Radiation Safety Officer, Cardiovascular Diagnostic Center.  Akron, OH.
  • 2001-2008 Director, Nuclear Cardiology, Akron Cardiology Consultants, Akron, OH.
  • 2001-2008 Radiation Safety Officer, Akron Cardiology Consultants, Akron, OH.
  • 2000- Attending Physician, Akron General Medical Center, Akron, OH.
  • 1999- Attending Physician, SUMMA Health System, Akron, OH.
  • 1999- Attending Physician, Children’s Hospital Medical Center of Akron, Akron, OH.
  • 1996-99 Westwood Cardiology Associates, Westwood, N.J. (Associate 1996-7; Partner 1997-9)
  • 1996-99 Assistant Attending Physician, Pascack Valley Hospital, Westwood, N.J.
  • 1996-99 Assistant Attending Physician, Valley Hospital, Ridgewood, N.J.
  • 1996-99 Assistant Attending Physician, Hackensack University Medical Center, N.J.
  • 1994-96 Associate, Cardiology and Internal Medicine Associates, Dallas, TX.
  • 1994-96 Attending Physician, Presbyterian Hospital of Dallas, Dallas & Greenville, TX.
  • 1994-96 Attending Physician, Doctors Hospital, Dallas, TX
  • 1994-96 Attending Physician, Medical City of Dallas, Dallas, TX
  • 1992-94 Attending Physician, St. Vincent Hospital, Worcester, MA, (Courtesy Staff)
  • 1989-93 Attending Physician, Milford-Whitinsville Regional Hospital, Milford, MA, (Courtesy Staff)
  • 1992-93 Weekend coverage for Drs. Moore and Sidhu (Private Cardiologists), Milford, MA.
  • 1992-93 Coordinator for Leominster Hospital ICU Moonlighting Program
  • 1989-91 Weekend coverage Tri-River Family Health Center Internal Medicine Group, Uxbridge and Milford, MA.
  • 1989-92 Coordinator for Tri-River Family Health Center Urgent Care Clinic
  • 1989, 91 Ward Attending Physician, U Massachusetts Medical Center & Worcester City Hospital, Worcester, MA.

Academic Appointments

  • 2014- Clinical Professor of Internal Medicine, Department of Internal Medicine, College of Medicine, Northeast Ohio Medical University (NEOMED), Rootstown, OH
  • 2012- Clinical Assistant Professor, Ohio State University College of Medicine, Columbus, Ohio.
  • 2013- Clinical Associate Professor of Cardiology, Ohio University College of Osteopathic Medicine, Athens, OH.
  • 2008-2013 Clinical Assistant Professor of Cardiology, Ohio University College of Osteopathic Medicine, Athens, OH.
  • 2006-2014 Associate Professor of Clinical Internal Medicine, Northeast Ohio Medical University (NEOMED), Rootstown, OH
  • 1999-2006 Assistant Professor of  Clinical Internal Medicine, Northeast Ohio Medical University (NEOMED), Rootstown, OH
  • 1997-2000 Clinical Assistant Professor of Medicine, Department of Internal Medicine.  University of Medicine and Dentistry of  New Jersey (UMDNJ), Newark, NJ.
  • 1989-93 Instructor of Clinical Medicine, University of Massachusetts Medical School, Worcester, MA.

Additional Courses

  • 2014 Summer Accounting BUS 500A, Baldwin Wallace University, Berea, OH
  • 2014 Fall Statistics 500Q, Baldwin Wallace University, Beachwood, OH
  • 2014 Spr & Fall History of Healthcare in the United States, Baldwin Wallace, Berea, OH
  • 2015 Winter Healthcare MBA Program, Baldwin Wallace University, Berea, OH
  • System and Organizational Design; Marketing; Finance
  • 2008-12 Advisory Board, Cardiovascular Roundtable.  Multiple courses on Leadership and Cardiovascular Innovation.

Committees

  • 2015- Chair, Ischemic Heart Disease Sub-Committee, Summa Cardiovascular Institute Quality Committee
  • 2014 Reviewer, Stem Cells Translational Medicine
  • 2014- Board Member, Summa Cardiovascular Institute
  • 2014- Executive Committee Member, Summa Cardiovascular Institute
  • 2011- Summa Physicians Incorporated Clinical Governing Board (SPI CGB) Member
  • 2011 - Chairman , SPI CGB Quality Committee
  • 2012- Executive Committee Member, Northeast Ohio Cardiovascular Specialists (NEOCS)
  • 2013-2014 At Large Member, Medical Executive Committee, SUMMA Health Systems
  • 2012-2013 Chairman of American Heart Association Heart Ball, Akron, OH
  • 2011-2014 Member, Board of Trustees, Ohio Chapter of American College of Cardiology
  • 2009-2012 Executive Committee Member, American Heart Association Mission: Lifeline
  • 2007-2009 Summa Health System Board of Directors, Physician Representative; Akron, OH
  • 2005 ABIM Relevance Reviewer for Interventional Cardiology Boards
  • 2005-2009 Co-Chair, Cardiovascular Quality Committee, SUMMA Health Systems
  • 2005-2006 Member, Cardiovascular Leadership Group, SUMMA Health Systems
  • 2003- 2006 Board of Trustees, American Heart Association, Akron, OH.
  • 2005 Co-chairman Sponsorship Sub-committee
  • 2002-2006 At Large Member, Medical Executive Committee, SUMMA Health Systems
  • 2001-2002 Faculty Council, Northeastern Ohio Universities College of Medicine (NEOUCOM)
  • 2000-2001 Volunteerism Task Force, Northeast Ohio University College of Medicine
  • 1999-2001 Committee of the Future, SUMMA Health Systems, Akron, OH
  • 1997- Member, Interventional Cardiology Committee, SCAI
  • 1998-99 Director, Graduate Medical Education, Pascack Valley Hospital
  • 1998-99 Member, Quality Improvement / Risk Management Committee, PVH
  • 1997-98 Member, Allied Health Group, Steering Committee for Cardiology, N.J.
  • 1995-96 Vice-Chairman, Critical Care Committee, Dallas, TX.

Licensures and Certifications

  • Certification in Healthcare Education, Case Western Reserve Weatherhead School of
  • Management, Cleveland 2007
  • Board Certification in Interventional Cardiology 2000 (recertified through 2020)
  • CBNC Certification in Nuclear Cardiology 1998 (recertified through 2018)
  • Board Certification in Cardiovascular Medicine 1993 (recertified through 2023)
  • Board Certification in Internal Medicine 1989 (no expiration)
  • Medical License, Ohio
  • BLS and ACLS Certified (exp. November 2015)

Memberships and Societies

  • Fellow, American College of Cardiology
  • Fellow, The Society for Cardiac Angiography and Interventions
  • Fellow, American Society of Nuclear Cardiology

Business Interests

  • Investor, Summa Western Reserve Partners

Hobbies & Activities

  • Kendo & Iaido (Japanese Samurai Sword Fighting)
  • Fountain Pen Collecting
  • Golf

Current Studies:

ODYSSEY-OUTCOMESPrincipal Investigator at SUMMA – Investigating clinical

outcomes in patients with ACS whose lipid levels are not at goal with maximal statin therapy.  Comparint the addition of placebo to PCSK-9.  On-going

RETRO-HFPrincipal Investigator at SUMMA – Coronary sinus  injection of SDF-1 encoding Plasmid to enhance Stem Cell homing in patients with ischemic cardiomyopathy.  On-going

STOP-HFPrincipal Investigator at SUMMA – Intramyocardial injection of SDF-1 encoding Plasmid to enhance Stem Cell homing in patients with ischemic cardiomyopathy.  Enrollment complete

IMPROVE-ITPrincipal Investigator at SUMMA – Studying the clinical outcomes of simvastatin vs simvastatin/ezetimibe  Follow-up phase

CANTOSPrincipal Investigator at SUMMA – Studying the clinical outcomes of a new anti-inflammatory monoclonal antibody on patients with prior MI and elevated hsCRP.  Enrollment complete

EXAMINE (Takeda)Principal Investigator at SUMMA – Studying the clinical effect of Alogliptin in patients with ACS and DM Type II.  Enrollment complete

PRE-DETERMINEPrincipal Investigator at SUMMA – NIH Trial.  Following serum markers in patients with prior MI to determine predictablility of event recurrence.  Enrollment complete

ANALYZE-ST Principal Investigator at SUMMAStudying the safety and effectiveness of the ST Monitoring Feature in the Fortify ST ICD system (or other ICD systems with the ST Monitoring Feature).   On-going

PEGASUS – Principal Investigator at SUMMA- Studying the clinical effect of ticagrelor in patients with history of MI and high risk of developing atherothrombotic events.    Enrollment complete

LAPTOP - SUMMA Site, Akron OH. Studying new ways to manage heart failure with Implanted Left Atrial Pressure (LAP) Monitoring System

ACCELERATEPrinciple Investigator at SUMMA:  CETP Inhibitor for patients at high risk for vascular outcomes.  Enrollment complete

Completed Studies:

1984-86nbsp;   Columbia University College of Physicians and Surgeons, NYC, NY.  Helped develop and validate a cinevideodensitometric analysis system for quantitating percent coronary  stenoses on coronary arteriograms.

1988-94nbsp;   University of Massachusetts Medical Center, Worcester, MA.  1) Studied coronary blood flow hemodynamics using a Doppler-tipped guidewire system; 2) Studied differences in cholesterol management after angioplasty in men and women; 3) Long axis shortening patterns in LVH; 4) Reactive versus passive pulmonary hypertension in aortic stenosis; 5) Myocardial hypertrophy in men and women.

1994-96 Dallas, TX,  Clinical Research:  1) Losartan for congestive heart failure;  2) Dofetilide for atrial fibrillation;  3)  dl-Sotalol for atrial fibrillation.

1996-99 Westwood, NJ:  AFFIRM Study.  Afib – rhythm control vs rate control and anticoagulation.  Westwood, NJ

Completed Studies at Summa Health Systems, Akron, OH:

TRACERPrincipal Investigator at SUMMA – Studying the effects of a novel thrombin receptor antagonist in NSTEMIs

CURRENT -   Principal Investigator.  SUMMA Site.  High vs intermediate dose Clopidogrel loading in Acute Coronary Syndromes.

OAT (Open Artery Trial) – Principal Investigator at SUMMA – Studying the “open artery hypothesis.”

VALIANT Trial -  Co-Investigator.  SUMMA Site, Akron, OH.  Valsartan and Enalapril in patients with reduced LV function.

EASE Trial -  Co-Investigator.  SUMMA Site, Akron, OH.  Zetia for hyperlipidemia.

EASE II Trial - Co-Investigator.  SUMMA Site, Akron, OH

SYNERGY Trial, Akron, OH.  Principal Investigator at SUMMA.

Use of LMWH vs UFH in Unstable Angina.

ADVANCET Trial -  Co-Investigator.  SUMMA Site, Akron, OH.  Guidant sponsored.

Registry for CHF Patients.

AMETHYST Trial -  Co-Investigator.  SUMMA Site, Akron, OH.  Novel distal protection filter for grafts in PCI.

OASIS 5 -  Co-Investigator.  SUMMA Site, Akron, OH.

Use of a novel platelet inhibitor in unstable angina.

WATCHMAN Trial - Co-Investigator, SUMMA Site, Akron, OH

Left atrial appendage occluder to prevent thromboembolism in atrial fibrillation without coumadin.

ENDEAVOR IV Trial - Co-Investigator, SUMMA Site, Akron, OH

Comparing everolimus coated versus paclitaxil coated stents for de-novo coronary lesions.

PROMISE - Studying if coronary CTA will improve clinical outcomes in subjects with  symptoms concerning for coronary artery disease

BIBLIOGRAPHY

Articles

Puliafico SB, Penn MS, Silver KH.  Stem Cell Therapy for Heart Disease Journal of General Internal Medicine 2013;10;1353-1363.

Penn MS, Silver KH.  Strategies for Cardiovascular Repair: Role of Stem Cells in 2012.  Minerva Cardioangiologica October 2012;60(5):451-60

McIntyre-Spatar LL, Silver KH.  Spontaneous coronary artery dissection in a postpartum woman: Literature review.  The Journal for Nurse Practitioners  2011;7(5):770-773.

Silver KH, Newman I, Rohr SM, Johnson J, Josephson RA.  Administration of a Glycoprotein IIb/IIIa Receptor Blocker with a Thienopyridine Derivative Does Not Increase the Risk of Thrombocytopenia.  Ohio J Sci 2005;4:74-78.

Rohr SM, Rich MW, Silver KH.  Shortness of Breath, Syncope, and Cardiac Arrest Caused by Systemic Mastocytosis.  Ann Emergency Med, 2005; 45(6):592-594.

Silver KH, Bauman WB, Berkovitz K.  Dual Chamber Covered Stenting: A Novel Approach to the Treatment of Large Coronary Artery Perforations.  J Invasive Cardiol 2003;15:348-350.

Aurigemma GP, Silver KH, Priest MA, Gaasch WH.  Geometric Changes Allow Normal Ejection Fraction Despite Depressed Myocardial Shortening in Hypertensive Left Ventricular Hypertrophy.  J Am Coll Cardiol 1995;26:195-202.

Heller LI, Silver KH, Villegas BJ, Balcom SJ, Weiner BH.  Blood Flow Velocity in the Right Coronary Artery: Assessment Before and After Angioplasty.  J Am Coll Cardiol 1994;24:1012-7.

Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH.  Impact of Chamber Geometry and Gender on Left Ventricular Systolic Function in Patients > 60 Years of Age with Aortic Stenosis.  Am J Cardiol  1994;74:794-798.

Silver KH, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J.  Pulmonary Artery Hypertension in Severe Aortic Stenosis: Incidence and Mechanism.  American Heart J   1993; 125:146-150

Silver K, Alpert J.  Syncope.  J Intensive Care Med. 1992; 7(3): 138-148.

Aurigemma G, Davidoff A, Silver K, Boehmer J.  Left Ventricular Mass Quantitation using Single Phase Cardiac Magnetic Resonance Imaging.  American J Cardiol. 1992; 70: 259-262.

Silver KH, Buczek JA, Esser PD, Nichols AB.  Quantitative Analysis of Coronary Arteriograms by Cinevideodensitometry.  Catheterization and Cardiovascular Diagnosis.  1987; 13: 291-300.

Abstracts

Rohr S, Johnson J, Silver K, Josephson R, Newman I.  Thrombocytopenia After Concomitant Administration of  a IIb-IIIa Receptor Inhibitor and a Theinopyridine Platelet Inhibitor.  Journal of General Internal Medicine 2002;17: 131.

Call DC, Silver KH, Trochelman RD, Josephson RA.  Hemostatic Effects of Ticlopidine and Clopidogrel Using High Shear Stress, High Flow in vitro Analysis.  Catheterization and Cardiovascular Intervention 2000; 50: 138.  [Poster presentation at the Society for Cardiac Angiography and Interventions, Charleston, SC, 5/2000.  PO04]

Silver KH, Heller LI, Hanna SR, Villegas BJ, Grella RD, Weiner BH.  The Use Of Pacing Catheters During PTCA Of The Right Coronary Artery.  [Poster presentation at

the Society for Cardiac Angiography and Interventions, Seattle, WA, 5/94]

Silver KH, Heller LI, Chung ES, Balcom SJ, Villegas BJ, Weiner BH.  Changes in Coronary Blood Flow Following Angioplasty in the Left Circumflex Coronary Artery. [Poster presentation at the Society for Cardiac Angiography and Interventions, Seattle, WA, 5/94]

Silver KH, Heller LI, Borbone ML, Weiner BH.  The Predictive Value of Chest Pain During PTCA.  [Poster presentation at the Society for Cardiac Angiography and Interventions, Seattle, WA, 5/94]

Silver KH, Weiner BH, Borbone ML, Heller LI, Jolie MN.  Serum Cholesterol Levels After Coronary Angioplasty in Men and Women.  J Am Coll Cardiol 1994; 299A. [Presented at the 43rd Scientific Session of the American College of Cardiology.]

Aurigemma GP, Silver KH, Fox MA, Gaasch WH.  Depressed Midwall and Long Axis Shortening in Hypertensive Left Ventricular Hypertrophy with Normal Ejection Fraction.  Circulation  1993; 88(4): 2688.

Heller LI, Silver KH, Villegas BJ, Balcom SJ, Weiner BH.  Changes in Coronary Blood Flow Following RCA PTCA.  Circulation  1993; 88 (4): 1087.

Aurigemma GP, Silver KH, Fox MA, Gaasch WH.  Left Ventricular Long Axis Shortening is Depressed in Compensated Pressure-Overload Hypertrophy.  Circulation 1992; 86 (4): 2146.  [Presented at the 65th Scientific Sessions of the American Heart Association, New Orleans, November, 1992.]

Aurigemma GP, Silver KH, McLaughlin M, Orsinelli D, Sweeney AM, Gaasch WH.  Gender Influences the Pattern of Left Ventricular Hypertrophy in Elderly Patients with Aortic Stenosis.  Circulation  1992; 86 (4): 2143.

Aurigemma GP, Davidoff A, Boehmer, Silver K.  Left Ventricular Mass Quantitation in Man Using Single-Phase Cardiac MRI.  J Am Coll Cardiol  1991; 17: 243A.

Silver KH, Aurigemma GP, Krendel SI, Barry N, Ockene IS, Alpert JS.  Mechanism of Pulmonary Artery Hypertension in Isolated, Severe Aortic Stenosis.  Circulation. 1990; 82: III-471 [Presented at the 63rd Scientific Sessions of the American Heart Association, Dallas, November, 1990.]

Silver KH, Irwin RS, Aurigemma GP.  Skiagraphy in a Patient with Cheyne-Stokes Respiration. [Presented at the Massachusetts Chapter of the American College of Physicians, Sturbridge, MA, October 1989.]

Nichols AB, Silver KH, Buczek JA.  Validation of a Cinevideodensitometric Microprocessor System for Measuring Coronary Stenotic Dimensions.  Circulation.  1986; 74: 485.

Case Reports

Hollingsworth HM, Silver KH, Irwin RS, Aurigemma GP.  Lethargy, Confusion, and a Mediastinal Abnormality in a 68-Year-Old Woman.  Chest 1994;106:939-941.

Mascarenhas DAN, Silver KH, Heller LI, Folland ED.  Intimal Invagination Due to Coronary Artery Straightening: A Temporary Iatrogenic Cause of Proximal Arterial Narrowing During Angioplasty.  J Invasive Cardiol  1993; 5(8): 302-305.

Silver KH, Folland ED.  Clinical Questions: Isolated Right Ventricular Failure.  Choices in  Cardiology.  1993;7(11): 374-377.

Silver KH, Alpert JS.  Acute Right Ventricular Failure with Rapid Resolution.  Primary       Cardiology. 1989; 15: 15-7.  (Reprinted in Physicians Assistant  11/89.)

Hendel R, Silver K, Cuenoud H, Pape L.  Giant Anomalous Band: An    Echocardiographic Diagnosis. American Journal of Noninvasive Cardiology.  1988; 2: 310-2.

Book Chapters

Silver KH, Aaron C.  Anticholinergic Toxicity.  in Rippe JM, Irwin RS, Alpert JS, Fink         MP (eds): Intensive Care Medicine, ed 2.  Boston, Little, Brown and Company, 1991, pp. 1122-1126.

Silver KH, Howe JP, Rippe JM.  Syncope,  in Rippe JM, Irwin RS, Alpert JS, Fink MP (eds):  Intensive Care Medicine, ed 2.  Boston, Little, Brown and Company, 1991, pp. 348-355.